Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Sigyn Therapeutics Inc (OP:SIGY)

4.150 +0.150 (+3.75%)
Streaming Delayed Price Updated: 3:31 PM EDT, Mar 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 200
Open 4.150
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 4.000
Today's Range 4.150 - 4.150
52wk Range 3.150 - 6.340
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Sigyn CEO Note: An Emerging New Industry, 15 Years in the Making
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Death
Exposures Death
Sigyn CEO Note: An Emerging New Industry, 15 Years in the Making
SAN DIEGO, CA - March 12, 2025 (NEWMEDIAWIRE) - Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY) today released the following note authored by its CEO, Jim Joyce. 
Via TheNewswire.com
Topics Death
Exposures Death

Performance

YTD
+29.7%
+29.7%
1 Month
+1.2%
+1.2%
3 Month
+29.7%
+29.7%
6 Month
-13.5%
-13.5%
1 Year
-30.8%
-30.8%

More News

Read More
Sigyn CEO Note: Combating the Rising Threat of New Pandemic Viruses
Via NewMediaWire
Exposures COVID-19 Product Safety
Sigyn CEO Note: Combating the Rising Threat of New Pandemic Viruses
Via TheNewswire.com
Exposures COVID-19 Product Safety
Sigyn Therapeutics to be Featured in Fireside Chat With Zacks Healthcare Analyst
Via NewMediaWire
Sigyn Therapeutics to Present at Tomorrow's Emerging Growth Conference
Via TheNewswire.com
Sigyn Therapeutics to be Featured in Fireside Chat With Zacks Healthcare Analyst
Via TheNewswire.com
Sigyn Therapeutics to Present at Tomorrow's Emerging Growth Conference
Via NewMediaWire
Small Cap Growth Virtual Investor Conference: Presentations Now Available for Online Viewing
From Virtual Investor Conferences
Via GlobeNewswire
Sigyn Therapeutics to Present at Tomorrow’s Small Cap Growth Virtual Investor Conference
From Virtual Investor Conferences
Via GlobeNewswire
Small Cap Growth Virtual Investor Conference Agenda Announced for February 6th
From Virtual Investor Conferences
Via GlobeNewswire
Sigyn Therapeutics Announces the Appointment of Michael Ryan to Its Board of Directors
Via NewMediaWire
Sigyn Therapeutics Announces the Appointment of Michael Ryan to Its Board of Directors
Via TheNewswire.com
OTCQB Venture Virtual Investor Conference Presentations Now Available for On-Demand Viewing
From Virtual Investor Conferences
Via GlobeNewswire
BioMedNewsBreaks — Sigyn Therapeutics Inc. (SIGY) Announces Q1 2024 Financial Results
Via Investor Brand Network
Topics Death
Exposures Death
Sigyn Therapeutics Reports First Quarter 2024 Financial Results
Via NewMediaWire
Sigyn Therapeutics Reports First Quarter 2024 Financial Results
Via TheNewswire.com
BioMedNewsBreaks – Sigyn Therapeutics Inc. (SIGY) Announces Publication of Article on Emerging Candidate – Sigyn Therapy(TM)
Via Investor Brand Network
Topics Death
Exposures COVID-19 Death
Sigyn Therapeutics Discloses Publication of "Sigyn Therapy, an Emerging Candidate to Address Endotoxemia, Sepsis, and Drug-Resistant Viral & Bacterial Infections"
Via NewMediaWire
Exposures COVID-19
BioMedNewsBreaks — Sigyn Therapeutics Inc. (SIGY) Leveraging Portfolio to Overcome Current Limitations in Healthcare
Via Investor Brand Network
Topics Death
Exposures Death
Sigyn Therapeutics Inc. (SIGY) CEO Discusses Company’s Blood Purification Therapies to Address Cancer and Other Life-Threatening Conditions at the Emerging Growth Conference
Via Investor Brand Network
BioMedNewsBreaks — Sigyn Therapeutics Inc. (SIGY) Making Drugs Perform Better
Via Investor Brand Network
Topics Death
Exposures Death
BioMedNewsBreaks — Sigyn Therapeutics Inc. (SIGY) Developing Innovative Technologies to Address Critical Healthcare Challenges
Via Investor Brand Network
Topics Death
Exposures Death
BioMedNewsBreaks – Sigyn Therapeutics Inc. (SIGY) Filling Gap in Therapeutic Antibody Treatment Space
Via Investor Brand Network
Topics Death
Exposures Death
BioMedNewsBreaks – Sigyn Therapeutics Inc. (SIGY) Announces CEO Presentation at Upcoming Emerging Growth Conference
Via Investor Brand Network
Topics Death
Exposures Death

Frequently Asked Questions

Is Sigyn Therapeutics Inc publicly traded?
Yes, Sigyn Therapeutics Inc is publicly traded.
What exchange does Sigyn Therapeutics Inc trade on?
Sigyn Therapeutics Inc trades on the OTC Traded
What is the ticker symbol for Sigyn Therapeutics Inc?
The ticker symbol for Sigyn Therapeutics Inc is SIGY on the OTC Traded
What is the current price of Sigyn Therapeutics Inc?
The current price of Sigyn Therapeutics Inc is 4.150
When was Sigyn Therapeutics Inc last traded?
The last trade of Sigyn Therapeutics Inc was at 03/31/25 03:31 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.